PALISADE BIO, INC. Business Combination, Contingent Consideration, Liability, Current
PALISADE BIO, INC. (PALI) had Business Combination, Contingent Consideration, Liability, Current of $235.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2025-11-10
- 2025-09-30: Business Combination, Contingent Consideration, Liability, Current $235.00K.
- 2025-06-30: Business Combination, Contingent Consideration, Liability, Current $66.00K.
- 2025-03-31: Business Combination, Contingent Consideration, Liability, Current $69.00K.
- 2024-12-31: Business Combination, Contingent Consideration, Liability, Current $0.00.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2025-09-30 | $235.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $66.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $69.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-10 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
| 2024-06-30 | $149.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $143.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $143.00K 10-K · filed 2025-03-24 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |